Concepedia

M.A. Tejani

MT

4

Publications

233

Citations

4

H-Index

2015

Active since

Affiliations

University of Rochester Medical Center(Current)

Indiana University – Purdue University Indianapolis

Indiana University Health

The Barbara Ann Karmanos Cancer Institute

University of Chicago

M.A. Tejani is an author at University of Rochester Medical Center specializing in oncology, medicine, and primary care.

Top concepts

Publications per year

2015–2024

4

Publications

4

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer

Bert H. O’Neil, Aaron J. Scott, W.W. Ma et al. · Annals of Oncology · 2015 · 140 citations · Full text

, , +9

Bemarituzumab With Modified Folfox6 For Advanced Fgfr2-Positive Gastroesophageal Cancer: Fight Phase Iii Study Design

Daniel V.T. Catenacci, Anteneh Tesfaye, M.A. Tejani et al. · Future Oncology · 2019 · 67 citations · Full text

Symptom experiences in patients with advanced pancreatic cancer as reported during healthcare encounters

Chia‐Chun Tang, Claire Burke Draucker, M.A. Tejani et al. · European Journal of Cancer Care · 2018 · 16 citations

, , +17

Effectiveness of Ventilation via an Endotracheal Tube in Pharynx Versus a Facemask in Patients With Potentially Difficult Airway: A Randomized, Crossover, and Blind Trial

Travis Markham, Abraham S. AlFarra, M.A. Tejani et al. · Anesthesia & Analgesia · 2024 · 10 citations

Rows per page

1–4 of 4